Literature DB >> 12114647

Vasculature in Nontumorous Hypophyses, Pituitary Adenomas, and Carcinomas: A Quantitative Morphologic Study.

Martin Jugenburg1, Kalman Kovacs, Lucia Stefaneanu, Bernd W. Scheithauer.   

Abstract

Vascular supply is essential for tumor proliferation and metastasis formation. Correlation was noted between vascular density and tumor size as well as metastases in several tumor types. The aim of the present study was to assess vascular density in nontumorous hypophyses, pituitary adenomas, primary pituitary carcinomas, and carcinomas metastatic to the pituitary. Twenty nontumorous hypophyses, 87 endocrinologically active or inactive pituitary adenomas, 8 primary pituitary carcinomas, 8 metastatic carcinomas, and 10 randomly selected noninvasive and 6 invasive adenomas were included in the study. Tissues were fixed in formalin, embedded in paraffin, cut, stained with hematoxylin and eosin, PAS, and immunostained for adenohypophysial hormones as well as Factor VIII-related antigen using the streptavidin-biotin-peroxidase complex method. Four counts were performed: percentage of capillary area, number of vessels per field, percentage of endothelial cells, and number of endothelial cells per field. The results show that pituitary adenomas have significantly lower vascular densities as compared to nontumorous adenohypophyses. Prolactin-producing adenomas removed from untreated patients have the highest counts and growth hormone-producing adenomas the lowest counts. However, the observed differences among adenoma types are not of statistical significance. No differences are noted between noninvasive and invasive tumors. Primary pituitary carcinomas show no significant increase in vascular densities. Some metastatic tumors exhibit high vascularity. It can be concluded that pituitary adenomas have a limited capacity to induce angiogenesis. Lack of significant angiogenesis may play a role in the slow pace of pituitary tumor growth and rarity of metastases.

Entities:  

Year:  1995        PMID: 12114647     DOI: 10.1007/bf02739874

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  34 in total

1.  Effect of dopamine agonist medication on prolactin producing pituitary adenomas. A morphological study including immunocytochemistry, electron microscopy and in situ hybridization.

Authors:  K Kovacs; L Stefaneanu; E Horvath; R V Lloyd; I Lancranjan; M Buchfelder; R Fahlbusch
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

2.  Cell proliferation and vascularization in human breast carcinomas.

Authors:  F Monschke; W U Müller; U Winkler; C Streffer
Journal:  Int J Cancer       Date:  1991-12-02       Impact factor: 7.396

3.  Vascular alterations in adenomas of human pituitary glands. An electron microscopic study.

Authors:  K Kovacs; E Horvath
Journal:  Angiologica       Date:  1973

4.  Arterial supply of the human anterior pituitary gland.

Authors:  W Gorczyca; J Hardy
Journal:  Neurosurgery       Date:  1987-03       Impact factor: 4.654

5.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.

Authors:  N Weidner; J P Semple; W R Welch; J Folkman
Journal:  N Engl J Med       Date:  1991-01-03       Impact factor: 91.245

6.  Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma.

Authors:  N Weidner; J Folkman; F Pozza; P Bevilacqua; E N Allred; D H Moore; S Meli; G Gasparini
Journal:  J Natl Cancer Inst       Date:  1992-12-16       Impact factor: 13.506

7.  Microvessel quantitation and prognosis in invasive breast carcinoma.

Authors:  S Bosari; A K Lee; R A DeLellis; B D Wiley; G J Heatley; M L Silverman
Journal:  Hum Pathol       Date:  1992-07       Impact factor: 3.466

8.  Morphological evidence for the presence of arteries in human prolactinomas.

Authors:  J Schechter; P Goldsmith; C Wilson; R Weiner
Journal:  J Clin Endocrinol Metab       Date:  1988-10       Impact factor: 5.958

9.  Specific alterations of the basement membrane and stroma antigens in human pituitary tumours in comparison with the normal anterior pituitary. An immunocytochemical study.

Authors:  M R Farnoud; B Lissak; M Kujas; F Peillon; J Racadot; J Y Li
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

10.  Intratumoral microvessel density and p53 protein: correlation with metastasis in head-and-neck squamous-cell carcinoma.

Authors:  G Gasparini; N Weidner; S Maluta; F Pozza; P Boracchi; M Mezzetti; A Testolin; P Bevilacqua
Journal:  Int J Cancer       Date:  1993-11-11       Impact factor: 7.396

View more
  30 in total

1.  Vascularity in Nontumorous Human Pituitaries and Incidental Microadenomas: A Morphometric Study.

Authors:  Sergio Vidal; Bernd W. Scheithauer; Kalman Kovacs
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

2.  Vasculogenic Mimicry in Clinically Non-functioning Pituitary Adenomas: a Histologic Study.

Authors:  Joseph Di Michele; Fabio Rotondo; Kalman Kovacs; Luis V Syro; George M Yousef; Michael D Cusimano; Antonio Di Ieva
Journal:  Pathol Oncol Res       Date:  2017-01-13       Impact factor: 3.201

Review 3.  Euclidean and fractal geometry of microvascular networks in normal and neoplastic pituitary tissue.

Authors:  Antonio Di Ieva; Fabio Grizzi; Paolo Gaetani; Umberto Goglia; Manfred Tschabitscher; Pietro Mortini; Riccardo Rodriguez y Baena
Journal:  Neurosurg Rev       Date:  2008-03-08       Impact factor: 3.042

4.  VEGF and CD31 association in pituitary adenomas.

Authors:  Carolina Cristina; María Inés Perez-Millan; Guillermina Luque; Raúl Ariel Dulce; Gustavo Sevlever; Silvia Inés Berner; Damasia Becu-Villalobos
Journal:  Endocr Pathol       Date:  2010-09       Impact factor: 3.943

Review 5.  Angiogenesis in prolactinomas: regulation and relationship with tumour behaviour.

Authors:  N Garcia de la Torre; H E Turner; J A H Wass
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

6.  Invasive giant prolactinoma with loss of therapeutic response to cabergoline: expression of angiogenic markers.

Authors:  María Susana Mallea-Gil; Carolina Cristina; María Inés Perez-Millan; Ana M Rodriguez Villafañe; Carolina Ballarino; Graciela Stalldecker; Damasia Becu-Villalobos
Journal:  Endocr Pathol       Date:  2009       Impact factor: 3.943

7.  Intraoperative indocyanine green videoangiography for identification of pituitary adenomas using a microscopic transsphenoidal approach.

Authors:  N Sandow; W Klene; U Elbelt; C J Strasburger; P Vajkoczy
Journal:  Pituitary       Date:  2015-10       Impact factor: 4.107

8.  Magnetic resonance imaging and biological markers in pituitary adenomas with invasion of the cavernous sinus space.

Authors:  Li-Xiong Pan; Zhong-Ping Chen; Yun-Sheng Liu; Ji-Hong Zhao
Journal:  J Neurooncol       Date:  2005-08       Impact factor: 4.130

9.  Inhibitory effects of anti-VEGF antibody on the growth and angiogenesis of estrogen-induced pituitary prolactinoma in Fischer 344 Rats: animal model of VEGF-targeted therapy for human endocrine tumors.

Authors:  Katsuhiro Miyajima; Susumu Takekoshi; Johbu Itoh; Kochi Kakimoto; Takashi Miyakoshi; Robert Yoshiyuki Osamura
Journal:  Acta Histochem Cytochem       Date:  2010-04-07       Impact factor: 1.938

10.  Changes in thrombospondin-1 levels in the endothelial cells of the anterior pituitary during estrogen-induced prolactin-secreting pituitary tumors.

Authors:  Abby J Sarkar; Kirti Chaturvedi; Cui Ping Chen; Dipak K Sarkar
Journal:  J Endocrinol       Date:  2007-02       Impact factor: 4.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.